Cranbury-based Rocket Pharmaceuticals on Wednesday appointed Martin Wilson — who has nearly 20 years of legal, compliance and executive experience and accomplishment within the life sciences industry — as senior vice president, chief compliance officer and general counsel.
Wilson will be responsible for the legal and compliance functions of the of the clinical-stage biotechnology company and serve as a key member of the leadership team.
“The Rocket family is thrilled to welcome Martin to our talented executive leadership team as we advance our world-class pipeline of gene therapies and unlock cures for patients facing devastating rare disease,” said Dr. Gaurav Shah, CEO of Rocket Pharma. “Martin’s vast legal and compliance expertise, coupled with exceptional leadership experiences at life science companies of varying sizes, scales our existing capabilities as we rapidly expand in support of our ambition to seek gene therapy cures.”
Prior to joining Rocket, Wilson was general counsel and chief corporate officer at Ichnos Sciences, where he oversaw legal, compliance, business development, human resources and IT. Wilson helped establish Ichnos as an independent corporate entity and set up its corporate structure. Before Ichnos, Wilson served as general counsel, chief compliance officer, corporate secretary and head of human resources at Teligent, and, prior to that, he was vice president and assistant general counsel at Endo Pharmaceuticals following the acquisition of Par Pharmaceuticals.
“Rocket’s dynamic culture, long-term vision and unyielding devotion to patients drew me to this opportunity,” Wilson said. “I’m excited to work with the Rocket leadership team and contribute to the company’s success as it advances first-in-class gene therapies for rare, devastating diseases.”
Earlier in his career, Wilson held a role in the licensing group at Schering-Plough. He earned his Juris Doctorate from Villanova University Charles Widger School of Law.